M. Rahnasto

Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids.

P. Imming, A. Meyer, H. Raunio, 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Nicotine metabolism and urinary elimination in mouse: in vitro and in vivo

T. Mauriala, S. Auriola, H. Raunio, 2008, Xenobiotica; the fate of foreign compounds in biological systems.

Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.

Antti Poso, Hannu Raunio, Carsten Wittekindt, 2005, Journal of medicinal chemistry.

Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme—an in silico approach

O Pelkonen, A. Poso, O. Pelkonen, 2008, The Pharmacogenomics Journal.

More potent inhibition of human CYP2A6 than mouse CYP2A5 enzyme activities by derivatives of phenylethylamine and benzaldehyde

A. Poso, H. Raunio, R. Juvonen, 2003, Xenobiotica; the fate of foreign compounds in biological systems.

Metabolism of bilirubin by human cytochrome P450 2A6.

A. Wikman, M. Lang, A. Abu-Bakar, 2012, Toxicology and applied pharmacology.

Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors.

Antti Poso, Hannu Raunio, Carsten Wittekindt, 2005, Journal of medicinal chemistry.

Identification of novel CYP2A6 inhibitors by virtual screening.

J. Leppänen, A. Poso, M. Lahtela-Kakkonen, 2011, Bioorganic & medicinal chemistry.

New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three‐dimensional quantitative structure‐activity relationship (3D‐QSAR) analysis

O Pelkonen, A. Poso, O. Pelkonen, 2007, British journal of pharmacology.